Apollo Hospitals Enterprise Full Year 2025 Earnings: In Line With Expectations

August 09, 2025

Simply Wall St

NSEI:APOLLOHOSP 1 Year Share Price vs Fair Value

Explore Apollo Hospitals Enterprise's Fair Values from the Community and select yours

Apollo Hospitals Enterprise (NSE:APOLLOHOSP) Full Year 2025 Results

Key Financial Results

Revenue: ₹217.9b (up 14% from FY 2024).
Net income: ₹14.5b (up 61% from FY 2024).
Profit margin: 6.6% (up from 4.7% in FY 2024). The increase in margin was driven by higher revenue.
EPS: ₹101 (up from ₹62.50 in FY 2024).

Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit.

earnings-and-revenue-growth — NSEI:APOLLOHOSP Earnings and Revenue Growth August 9th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Apollo Hospitals Enterprise Meets Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) was also in line with analyst expectations.

Looking ahead, revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Healthcare industry in India.

Performance of the Indian Healthcare industry.

The company's shares are down 3.6% from a week ago.

Balance Sheet Analysis

While it's very important to consider the profit and loss statement, you can also learn a lot about a company by looking at its balance sheet. We have a graphic representation of Apollo Hospitals Enterprise's balance sheet and an in-depth analysis of the company's financial position.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.